HF
QNTM

HRT Financial’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

HRT Financial’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,041
Closed -$40K – 3417
2024
Q3 		$40K Buy
10,041
+9,793
+3,949% +$61K ﹤0.01% 2134
2024
Q2 		$2K Buy
+248
New +$6.05K ﹤0.01% 2089
2023
Q4 		– Sell
-169
Closed -$13K – 3210
2023
Q3 		$13K Buy
+169
New +$13.8K ﹤0.01% 2106

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

HRT Financial's QNTM Position: Q4 2024 in Review

HRT Financial sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2024, closing a stake of 10,041 shares — an estimated $40K sold.

HRT Financial first reported a position in QNTM in Q3 2023 and held it in 3 quarters. The position peaked at $40K in Q3 2024. 9 funds tracked by Wall St. Rank hold QNTM as of Q4 2024.

  • HRT Financial reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 10,041 Quantum Biopharma Class B Subordinate Voting Shares shares in Q4 2024, an estimated $40K.
  • HRT Financial first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2023 and held it in 3 quarters.
  • HRT Financial's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $40K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.